Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "Life-Sciences"

668 News Found

SRMIST to host global physiotherapy and hand rehabilitation conclave on 16-18 April
News | April 13, 2026

SRMIST to host global physiotherapy and hand rehabilitation conclave on 16-18 April

The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students


Merck India, MAHE launch catalyst program to build future R&D talent pipeline
R&D | April 13, 2026

Merck India, MAHE launch catalyst program to build future R&D talent pipeline

MoU aims to strengthen academia-industry collaboration in healthcare research and innovation


India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap
Biopharma | April 13, 2026

India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap

The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness


Zydus improves ESG rating to 68, up from 66 last year
News | April 11, 2026

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker


Biocon appoints Mandar Ghatnekar as Chief Technology Officer
People | April 10, 2026

Biocon appoints Mandar Ghatnekar as Chief Technology Officer

Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role


India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi
Policy | April 09, 2026

India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi

Discussions are likely to centre on how the country can move up the pharmaceutical value chain


Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health
News | April 08, 2026

Regeneron and TriNetX forge $200M partnership to supercharge drug discovery and digital health

TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners


Zydus gets USFDA final approval for generic Dapagliflozin with 180-day shared exclusivity
Drug Approval | April 08, 2026

Zydus gets USFDA final approval for generic Dapagliflozin with 180-day shared exclusivity

Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility


Merck expands Bengaluru plant to strengthen global filtration supply chain
Supply Chain | April 08, 2026

Merck expands Bengaluru plant to strengthen global filtration supply chain

New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network